BURNABY, BC,
March 1, 2013 /CNW/ - Welichem
Biotech Inc. (the "Company") (TSX-V: WBI), announced today that
Mrs. Lijuan Pang has resigned as a
director of the Company effective March 1,
2013.
The Company has valued the contribution of Mrs.
Pang as a director of the Company over the past one and half years
and wishes her success in her future endeavours.
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded
biotechnology company developing therapeutic drugs in the fields of
autoimmune diseases and cancer. For a more complete business and
financial profile of the Company, interested parties are encouraged
to visit the Company's website, www.welichem.com.
The TSX Venture Exchange has not reviewed and
does not accept responsibility for the adequacy or accuracy of the
content of this news release. This press release contains
forward-looking statements that include our belief as to the
potential of our products. Certain risks and uncertainties such as
our ability to successfully commercialize the products could cause
the Company's actual results to differ materially from those in the
forward-looking statements.
SOURCE Welichem Biotech Inc.